Prelude Therapeutics Incorporated PRLD
3.72 USD -0.36 (-8.82%)
Nov 5, 2026, 11:39 AM EST
3.66 Day range 4.13
1.17 52-week range 6.83
- YTD
- +28.28%
- 1 year
- +167.63%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 12.14M | 7.00M | 0 | 0 | 0 | |
| 12.14M | 7.00M | 0 | 0 | 0 | |
| -104.57M | -139.71M | -132.28M | -123.54M | -113.73M | |
| -99.50M | -127.17M | -121.83M | -115.44M | -111.69M | |
| -1.29 | -1.68 | -2.02 | -2.44 | -2.43 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 38.49M | 16.52M | 29.34M | 34.65M | 35.87M | |
| 141.31M | 175.51M | 277.67M | 220.50M | 305.10M | |
| 72.68M | 44.06M | 40.58M | 25.06M | 19.20M | |
| 17.79M | 18.02M | 16.89M | 1.83M | 1.74M | |
| 68.64M | 131.46M | 237.09M | 195.44M | 285.90M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -56.30M | -102.89M | -107.06M | -83.73M | -83.53M | |
| 53.46M | 90.19M | -34.65M | 81.69M | -263.80M | |
| 24.82M | -120.00K | 136.40M | 815.00K | 164.90M | |
| -67.00K | -764.00K | -3.51M | -3.02M | -2.32M | |
| 21.97M | -12.82M | -5.31M | -1.22M | -182.44M |